Skip to content
  • ENGLISHENGLISH
  • 繁體中文繁體中文
回首頁回首頁回首頁
  • About Alar
    • Company Profile
    • Leadership Team
    • History&Milestones
  • Products
    • Products Pipeline
    • Contract Manufacturing
  • Media
    • News
    • Event
    • Knowledge
  • Investors
    • Shareholder Services
    • Financials
    • Corporate Governance
  • Contact Us
MENU Close

2020/08/03 ALA -1000 Receive notice of patent allowance from the IP Australia.

2020/08/03 ALA -1000 Receive notice of patent allowance from the IP Australia.

  • Post author:alarpharm
  • Post published:25 . 8 . 2020
  • Post category:Media releases

You Might Also Like

2021/08/25 ALA-1000 Receive notice of patent allowance from South Africa-Companies and Intellectual Property Commission Department of Trade and Industry (CIPC), Application No. 2019/00890.

3 . 9 . 2021

2021/08/03 ALA-1000 Receive notice of patent allowance from Japan Patent Office (JPO), Application No. 特願2019-535434.

9 . 8 . 2021

2021/05/10 ALA-1000 Receive notice of patent allowance from Innovation, Science and Economic Development Canada (ISED), Application No.3,033,046

8 . 6 . 2021

2021/10/28 Alar Pharmaceuticals Inc. Completes Successful End-of-Phase 2 Meeting with US FDA for ALA-1000 for the Treatment of Opioid Use Disorder

28 . 10 . 2021

2021/04/12 ALA-1000 Receive Decision of Grant from Federal Service for Intellectual Property (ROSPATENT) (Application No. 2019102895).

21 . 4 . 2021
  • News
  • Event
  • Knowledge
回首頁

ABOUT

  • Company Profile
  • Leadership Team
  • History&Milestones
  • Company Profile
  • Leadership Team
  • History&Milestones

PRODUCTS

  • Products Pipeline
  • Contract Manufacturing
  • Products Pipeline
  • Contract Manufacturing

media

  • News
  • Event
  • Knowledge
  • News
  • Event
  • Knowledge

investors

  • Shareholder Services
  • Financials
  • Corporate Governance
  • Shareholder Services
  • Financials
  • Corporate Governance

CONTACT us

  • Contact Us
  • Contact Us
  • Contact Us
  • Privacy Policy
Copyright © - 2022 Alar Pharmaceuticals Inc . All right reserved.
Close
  • About Alar
    • Company Profile
    • Leadership Team
    • History&Milestones
  • Products
    • Products Pipeline
    • Contract Manufacturing
  • Media
    • News
    • Event
    • Knowledge
  • Investors
    • Shareholder
    • Financials
    • Corporate Governance
  • Contact Us
    • Contact Us
×

Cart